$3.01
0.041.35%
At close: -
$3.10
0.092.99%
After Hours: 7:58 PM EDT
Comments
Loading...
aTyr Pharma (ATYR) Forecast
NewsEarningsaTyr Pharma (ATYR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
aTyr Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATYR | Benzinga
Explore aTyr Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATYR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy aTyr Pharma (ATYR) stock?
You can purchase shares of aTyr Pharma (NASDAQ:ATYR) through any online brokerage.
Who are aTyr Pharma (ATYR) competitors?
Other companies in aTyr Pharma’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Monte Rosa Therapeutics (NASDAQ:GLUE), Olema Pharmaceuticals (NASDAQ:OLMA) and Emergent BioSolutions (NYSE:EBS).
What is the forecast, or price target, for aTyr Pharma (ATYR) stock?
aTyr Pharma has a consensus price target of $18.60.
What is the current price for aTyr Pharma (ATYR)?
The stock price for aTyr Pharma (NASDAQ: ATYR) is $3.1 last updated April 14, 2025 at 7:58 PM EDT.
Does aTyr Pharma (ATYR) pay a dividend?
There are no upcoming dividends for aTyr Pharma.
When is aTyr Pharma (NASDAQ:ATYR) reporting earnings?
aTyr Pharma’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is aTyr Pharma (ATYR) going to split?
There is no upcoming split for aTyr Pharma.
What sector and industry does aTyr Pharma (ATYR) operate in?
aTyr Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.